The Center for Dairy Research (CDR) has launched an initiative aimed at fostering innovation in the dairy sector. The Accelerate Biotechnological Innovations in Dairy (ABID) grant program invites entrepreneurs, scientists, and established companies to explore innovative ways to repurpose dairy co-products, such as permeate and acid whey. By transforming these byproducts into valuable products like bioplastics, organic acids, and food ingredients, the program seeks to enhance sustainability and profitability in the dairy industry.
Access to Advanced Facilities
One of the key features of the ABID grant program is the access it provides to CDR’s newly established pilot plant. This facility is specifically designed for the development and scaling of technologies that utilize dairy byproducts. Selected applicants will benefit from the resources available at this pilot plant, allowing them to test and refine their innovative solutions.
State-of-the-Art Bioreactor
A central component of the ABID program is the inclusion of a 400L bioreactor. This state-of-the-art equipment is crucial for advancing bio-fermentation technology aimed at converting dairy co-products into higher-value green chemicals. The bioreactor boasts a stainless-steel, sterilize-in-place (SIP) design, complemented by advanced Allen Bradley® PLC automation. This setup allows for precise control over critical parameters, including temperature, pH, aeration, and agitation.
These controls are vital for ensuring process reproducibility and scaling up production. The bioreactor will support a variety of applications, including lactic acid bacteria fermentation, enzyme production, prebiotic and postbiotic synthesis from dairy substrates, and the transformation of lactose-rich waste into functional ingredients. Such capabilities will aid in optimizing processes for food, nutraceutical, and biopolymer applications.
Bridging Research and Industry
To facilitate innovation and commercialization in the dairy and bioprocessing sectors, CDR offers strategic business development funding through the ABID grant program and related state initiatives. These funding opportunities aim to bridge the gap between academic research and industrial application. They support early-stage technology validation, pilot-scale trials, and the translation of research into market-ready products.
Collaborations for Risk Reduction
The CDR actively collaborates with startups, processors, and academic institutions, both domestically and internationally. This collaborative approach is designed to de-risk innovation and expand the bioeconomy footprint of the state. By working with qualifying entities, the ABID program creates a supportive ecosystem for the development and commercialization of novel dairy technologies.
Key Benefits of Participation
Entities that qualify for the ABID grant program can expect several benefits:
- Access to cutting-edge bioreactor and pilot plant facilities.
-
Strategic business development funding to support technology validation and scaling.
-
Opportunities to collaborate with experienced researchers and industry experts.
-
Support in navigating the commercialization process, from initial research to market entry.
Conclusion
The ABID grant program at the Center for Dairy Research represents a significant opportunity for innovators in the dairy sector. By providing essential resources, funding, and collaborative support, CDR is paving the way for a more sustainable and profitable dairy industry. This initiative not only encourages the upcycling of dairy byproducts but also enhances the overall bioeconomy, positioning participants at the forefront of dairy innovation.
- The ABID grant program targets innovative uses for dairy co-products.
-
Access to a 400L bioreactor and pilot plant accelerates technology development.
-
Strategic funding bridges the gap between research and market application.
-
Collaborations with diverse stakeholders enhance innovation potential.
-
The program aims to expand sustainability and profitability in the dairy sector.
Read more → wtaq.com